JP2021517026A - 渦カプセル空洞を備えた吸入器 - Google Patents
渦カプセル空洞を備えた吸入器 Download PDFInfo
- Publication number
- JP2021517026A JP2021517026A JP2020547062A JP2020547062A JP2021517026A JP 2021517026 A JP2021517026 A JP 2021517026A JP 2020547062 A JP2020547062 A JP 2020547062A JP 2020547062 A JP2020547062 A JP 2020547062A JP 2021517026 A JP2021517026 A JP 2021517026A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- cavity
- inhaler
- inhaler article
- capsule cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 274
- 239000002245 particle Substances 0.000 claims description 134
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 50
- 229960002715 nicotine Drugs 0.000 claims description 46
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 46
- 230000000149 penetrating effect Effects 0.000 claims description 25
- 229920002678 cellulose Polymers 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 229920000297 Rayon Polymers 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 2
- 238000010586 diagram Methods 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 description 70
- 235000019634 flavors Nutrition 0.000 description 51
- 239000000843 powder Substances 0.000 description 51
- 239000000463 material Substances 0.000 description 35
- 235000013355 food flavoring agent Nutrition 0.000 description 19
- 239000000779 smoke Substances 0.000 description 13
- 229920002301 cellulose acetate Polymers 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- 230000003434 inspiratory effect Effects 0.000 description 12
- 230000000391 smoking effect Effects 0.000 description 12
- 230000009102 absorption Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000009987 spinning Methods 0.000 description 10
- 239000000123 paper Substances 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 210000000214 mouth Anatomy 0.000 description 8
- 235000019504 cigarettes Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 4
- 229940112141 dry powder inhaler Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 3
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- -1 salt hydrates Chemical class 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- JZBCTZLGKSYRSF-UHFFFAOYSA-N 2-Ethyl-3,5-dimethylpyrazine Chemical compound CCC1=NC=C(C)N=C1C JZBCTZLGKSYRSF-UHFFFAOYSA-N 0.000 description 2
- MMOPGICOOYBFJU-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.CN1CCCC1C1=CC=CN=C1 MMOPGICOOYBFJU-UHFFFAOYSA-N 0.000 description 2
- FFYVQVZXWDGRAY-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrate Chemical compound O.CN1CCCC1C1=CC=CN=C1 FFYVQVZXWDGRAY-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000011087 paperboard Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229940070710 valerate Drugs 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- GKTOAHZEMRRUKF-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)[C@@H](N)CCC(O)=O.CN1CCCC1C1=CC=CN=C1 GKTOAHZEMRRUKF-HVDRVSQOSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- SKZDZXPBBYUFBY-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCCC1C1=CC=CN=C1 SKZDZXPBBYUFBY-WLHGVMLRSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- 239000001363 2-ethyl-3,5-dimethylpyrazine Substances 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- VWTHFJXLFGINSW-PPHPATTJSA-N 2-hydroxypropanoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CC(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 VWTHFJXLFGINSW-PPHPATTJSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- YKVWPZJHENXDAJ-VOTSOKGWSA-N Megastigmatrienone Chemical compound CC1=CC(=O)CC(C)(C)C1\C=C\C=C YKVWPZJHENXDAJ-VOTSOKGWSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 239000011295 pitch Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000004084 sesquiterpene group Chemical group 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- PQDRXUSSKFWCFA-CFNZNRNTSA-N solanone Chemical compound CC(=O)CC[C@@H](C(C)C)\C=C\C(C)=C PQDRXUSSKFWCFA-CFNZNRNTSA-N 0.000 description 1
- PQDRXUSSKFWCFA-UHFFFAOYSA-N solanone Natural products CC(=O)CCC(C(C)C)C=CC(C)=C PQDRXUSSKFWCFA-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/60—Constructional details
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/08—Use of materials for tobacco smoke filters of organic materials as carrier or major constituent
- A24D3/10—Use of materials for tobacco smoke filters of organic materials as carrier or major constituent of cellulose or cellulose derivatives
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F1/00—Tobacco pipes
- A24F1/02—Tobacco pipes with arrangements for cleaning or cooling the smoke
- A24F1/16—Tobacco pipes with arrangements for cleaning or cooling the smoke with zigzag or like passages for the smoke
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/20—Devices without heating means
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F5/00—Bowls for pipes
- A24F5/04—Bowls for pipes with holes for admitting air
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F7/00—Mouthpieces for pipes; Mouthpieces for cigar or cigarette holders
- A24F7/04—Mouthpieces for pipes; Mouthpieces for cigar or cigarette holders with smoke filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
Abstract
Description
Claims (16)
- 吸入器物品であって、
マウスピース端から遠位端に長軸方向軸に沿って延びる本体と、
前記遠位端にあるエンドピース要素と、
前記本体内に画定され、前記長軸方向軸に沿って空洞の長さに延びるカプセル空洞であって、前記カプセル空洞の内表面上または内表面内にらせん状の特徴を含み、前記らせん状の特徴が前記空洞の長さに沿って延びる、カプセル空洞と、
前記エンドピース要素と前記カプセル空洞との間の空気吸込み口領域であって、空気吸込み口および前記空気吸込み口から前記カプセル空洞に延びる空気通路を有する、空気吸込み口領域と、
前記カプセル空洞の下流端を画定する多孔性要素と、
前記カプセル空洞から、前記多孔性要素を通って前記マウスピース端に延びるマウスピース空気チャネルと、を備える、吸入器物品。 - 前記らせん状の特徴が、前記カプセル空洞の前記内表面の中へと陥凹した溝またはチャネルである、請求項1に記載の吸入器物品。
- 前記らせん状の特徴が、前記カプセル空洞の前記内表面から離れるように延びる突出部である、請求項1または請求項2に記載の吸入器物品。
- 前記らせん状の特徴が、前記内表面の周り一フル回転の少なくとも約50%回転する、請求項1〜3のいずれかに記載の吸入器物品。
- 前記らせん状の特徴が約2mm〜約8mmの範囲のピッチを有する、請求項1〜4のいずれかに記載の吸入器物品。
- 前記らせん状の特徴が二つのらせん状の特徴を含む、請求項1〜5のいずれかに記載の吸入器物品。
- 前記らせん状の特徴が三つ以上のらせん状の特徴を含む、請求項1〜6のいずれかに記載の吸入器物品。
- 前記らせん状の特徴が、前記空洞の長さに沿って相互に均等に間隙を介している、請求項6または7に記載の吸入器物品。
- 前記空気吸込み口領域が、前記カプセル空洞内に吸入気流の渦を誘発する、請求項1〜8のいずれかに記載の吸入器物品。
- 空気吸込み口領域が、前記空気通路を画定する開いた円筒である渦トンネルを含み、前記空気通路が前記開いた円筒の長軸方向軸に沿って実質的に同軸に延び、前記渦トンネルが前記開いた円筒の内径の接線にて前記空気通路に入る二つの対向する空気吸込み口を含む、請求項9に記載の吸入器物品。
- 前記エンドピース要素が、前記遠位端を通る前記カプセル空洞への気流を制限または防止するように構成される、請求項1〜10のいずれかに記載の吸入器物品。
- 前記エンドピース要素が、約100水柱mmよりも大きい引き出し抵抗(RTD)を有し、前記エンドピース要素が、セルロースおよびアセテート、繊維およびトウ、ならびにビスコース紙のうちの少なくとも一つから形成される、請求項1〜11のいずれかに記載の吸入器物品。
- 請求項1〜12のいずれか一項に記載の吸入器物品と、前記吸入器物品の前記カプセル空洞内に配置されたカプセルとを備え、前記カプセルが粒子を含有し、前記粒子が、約5マイクロメートル以下、または約0.5マイクロメートル〜約4マイクロメートルの範囲、または約1マイクロメートル〜約3マイクロメートルの範囲の空気動力学的中央粒子径を有する、吸入器システム。
- 前記カプセルがニコチンを含む粒子を含有する、請求項13に記載のシステム。
- 前記カプセルが、約20マイクロメートル以上、または約50マイクロメートル以上、または約50〜約200マイクロメートルの範囲、または約50〜約150マイクロメートルの範囲の空気動力学的中央粒子径を有する風味粒子の第二の集団をさらに含有する、請求項13または請求項14に記載のシステム。
- 前記システムが、前記カプセルを有効化するために前記吸入器物品と取り外し可能なように係合可能な貫通要素をさらに備え、前記エンドピース要素が、前記カプセルを有効化する時に前記貫通要素によって貫通されるように構成される、請求項13〜15のいずれか一項に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18164077.2 | 2018-03-26 | ||
EP18164077 | 2018-03-26 | ||
PCT/IB2019/052412 WO2019186372A1 (en) | 2018-03-26 | 2019-03-25 | Inhaler with vortex capsule cavity |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021517026A true JP2021517026A (ja) | 2021-07-15 |
JPWO2019186372A5 JPWO2019186372A5 (ja) | 2022-03-14 |
JP7360392B2 JP7360392B2 (ja) | 2023-10-12 |
Family
ID=61800431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020547062A Active JP7360392B2 (ja) | 2018-03-26 | 2019-03-25 | 渦カプセル空洞を備えた吸入器 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11964099B2 (ja) |
EP (1) | EP3772258B1 (ja) |
JP (1) | JP7360392B2 (ja) |
KR (1) | KR20200131248A (ja) |
CN (1) | CN111867662B (ja) |
BR (1) | BR112020016652A2 (ja) |
WO (1) | WO2019186372A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110831448B (zh) | 2017-03-17 | 2023-04-25 | 瑞恩·丹尼尔·塞尔比 | 封闭底部的气化器荚 |
US20220379051A1 (en) * | 2019-10-25 | 2022-12-01 | Philip Morris Products S.A. | Inhaler article with open distal end, and inhaler system |
CN114555161A (zh) | 2019-10-25 | 2022-05-27 | 菲利普莫里斯生产公司 | 具有折叠远端的吸入器制品 |
KR20220145819A (ko) * | 2020-02-26 | 2022-10-31 | 필립모리스 프로덕츠 에스.에이. | 고 장벽 분말 캡슐 |
KR20230043142A (ko) * | 2020-07-24 | 2023-03-30 | 필립모리스 프로덕츠 에스.에이. | 흡입기 물품 |
WO2024026704A1 (zh) * | 2022-08-03 | 2024-02-08 | 常州市派腾电子技术服务有限公司 | 雾化器及气溶胶发生装置 |
KR20240061881A (ko) * | 2022-11-01 | 2024-05-08 | 주식회사 케이티앤지 | 흡입기 |
KR20240062581A (ko) * | 2022-11-02 | 2024-05-09 | 주식회사 케이티앤지 | 흡입기 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49130094A (ja) * | 1973-04-13 | 1974-12-12 | ||
JPS5045495A (ja) * | 1973-08-24 | 1975-04-23 | ||
JPH09501581A (ja) * | 1993-08-18 | 1997-02-18 | フアイソンズ・ピーエルシー | 吸息率制御器を備えた吸入装置 |
JP2003508184A (ja) * | 1999-07-23 | 2003-03-04 | ファーマシューティカル ディスカバリー コーポレイション | 単位用量カプセルおよび乾燥粉末吸入器 |
US20040206350A1 (en) * | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber |
JP2006026436A (ja) * | 1995-01-23 | 2006-02-02 | Direct-Haler As | 吸入器 |
WO2015166350A2 (en) * | 2014-04-28 | 2015-11-05 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
WO2017109626A1 (en) * | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Nicotine powder delivery system |
WO2017109678A1 (en) * | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Nicotine particle capsule |
WO2017207586A1 (en) * | 2016-05-31 | 2017-12-07 | Philip Morris Products S.A. | Aerosol-generating system comprising a heated aerosol-generating article |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080138398A1 (en) * | 1999-07-16 | 2008-06-12 | Aradigm Corporation | Dual release nicotine formulations, and systems and methods for their use |
KR101338969B1 (ko) * | 2004-11-10 | 2013-12-10 | 씨아이피엘에이 엘티디. | 흡입기 |
US9609893B2 (en) | 2013-03-15 | 2017-04-04 | Rai Strategic Holdings, Inc. | Cartridge and control body of an aerosol delivery device including anti-rotation mechanism and related method |
SG11201610498PA (en) | 2014-06-20 | 2017-01-27 | Philip Morris Products Sa | Nicotine powder delivery system with airflow management means |
US20170071248A1 (en) * | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
GB201605105D0 (en) * | 2016-03-24 | 2016-05-11 | Nicoventures Holdings Ltd | Vapour provision apparatus |
US10918135B2 (en) | 2016-05-31 | 2021-02-16 | Altria Client Services Llc | Heat diffuser for an aerosol-generating system |
EP3481471B1 (en) | 2016-07-07 | 2020-08-26 | Philip Morris Products S.a.s. | Nicotine inhaler system |
KR102494208B1 (ko) | 2016-11-30 | 2023-02-02 | 필립모리스 프로덕츠 에스.에이. | 소용돌이 단부 플러그를 갖는 흡입기 |
US20190124983A1 (en) * | 2017-11-02 | 2019-05-02 | Avail Vapor, LLC | Micro-vaporizer with leak protection |
JP2021509297A (ja) * | 2017-12-28 | 2021-03-25 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 渦トンネルを備えた吸入器 |
WO2019186395A1 (en) * | 2018-03-26 | 2019-10-03 | Philip Morris Products S.A. | Inhaler with composite porous support element |
-
2019
- 2019-03-25 JP JP2020547062A patent/JP7360392B2/ja active Active
- 2019-03-25 EP EP19721073.5A patent/EP3772258B1/en active Active
- 2019-03-25 WO PCT/IB2019/052412 patent/WO2019186372A1/en active Search and Examination
- 2019-03-25 KR KR1020207026561A patent/KR20200131248A/ko active IP Right Grant
- 2019-03-25 US US17/040,220 patent/US11964099B2/en active Active
- 2019-03-25 BR BR112020016652-9A patent/BR112020016652A2/pt unknown
- 2019-03-25 CN CN201980017201.3A patent/CN111867662B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49130094A (ja) * | 1973-04-13 | 1974-12-12 | ||
JPS5045495A (ja) * | 1973-08-24 | 1975-04-23 | ||
JPH09501581A (ja) * | 1993-08-18 | 1997-02-18 | フアイソンズ・ピーエルシー | 吸息率制御器を備えた吸入装置 |
JP2006026436A (ja) * | 1995-01-23 | 2006-02-02 | Direct-Haler As | 吸入器 |
JP2003508184A (ja) * | 1999-07-23 | 2003-03-04 | ファーマシューティカル ディスカバリー コーポレイション | 単位用量カプセルおよび乾燥粉末吸入器 |
US20040206350A1 (en) * | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber |
WO2015166350A2 (en) * | 2014-04-28 | 2015-11-05 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
WO2017109626A1 (en) * | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Nicotine powder delivery system |
WO2017109678A1 (en) * | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Nicotine particle capsule |
WO2017207586A1 (en) * | 2016-05-31 | 2017-12-07 | Philip Morris Products S.A. | Aerosol-generating system comprising a heated aerosol-generating article |
Also Published As
Publication number | Publication date |
---|---|
BR112020016652A2 (pt) | 2020-12-15 |
EP3772258C0 (en) | 2023-10-25 |
EP3772258B1 (en) | 2023-10-25 |
CN111867662A (zh) | 2020-10-30 |
EP3772258A1 (en) | 2021-02-10 |
US11964099B2 (en) | 2024-04-23 |
KR20200131248A (ko) | 2020-11-23 |
RU2020131563A (ru) | 2022-04-26 |
US20210008307A1 (en) | 2021-01-14 |
WO2019186372A1 (en) | 2019-10-03 |
CN111867662B (zh) | 2022-09-23 |
JP7360392B2 (ja) | 2023-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7249354B2 (ja) | 開口部付きの多孔性支持要素を備えた吸入器 | |
JP7360392B2 (ja) | 渦カプセル空洞を備えた吸入器 | |
JP7061124B2 (ja) | 渦巻状端部プラグを備えた吸入器 | |
JP7458985B2 (ja) | 複合多孔性支持要素を備えた吸入器 | |
US11744960B2 (en) | Inhaler with vortex tunnel | |
JP7242300B2 (ja) | ニコチン粒子カプセル | |
JP7061123B2 (ja) | サイズ設定された空洞を備えた吸入器 | |
JP2021500015A (ja) | 境界要素を備えた吸入器 | |
RU2783305C2 (ru) | Ингалятор с составным пористым опорным элементом | |
RU2783884C2 (ru) | Ингалятор с вихревой полостью для капсулы | |
RU2778721C2 (ru) | Ингалятор с вихревым каналом |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220228 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220228 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221205 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221212 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230413 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230831 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230929 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7360392 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |